{"id":"W4392125931","doi":"10.1093/ofid/ofae102","title":"COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)—a Randomized Controlled Clinical Trial","year":2024,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Niagara Health System; Sunnybrook Health Science Centre; Institute of Infection and Immunity; University of British Columbia; Health Sciences Centre; McGill University","funders":"Fonds de Recherche du Québec - Santé; Sanofi Genzyme; Bausch Health; LEO Pharma; Galderma; Novartis Pharmaceuticals Corporation; AbbVie; Sanofi; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Omalizumab; Coronavirus disease 2019 (COVID-19); Randomized controlled trial; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Virology; Intensive care medicine; Immunology; Antibody; Internal medicine; Immunoglobulin E; Outbreak","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003390367,0.00169266,0.004105626,0.000589549,0.0005360063,0.001668039,0.001098506,0.002652168,0.008377435],"category_scores_gemma":[0.004047026,0.0006332787,0.002940753,0.0006642438,0.001236734,0.001145415,0.0004963377,0.002384725,0.0007465883],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008240282,"about_ca_system_score_gemma":0.001422947,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007629716,"about_ca_topic_score_gemma":0.001236047,"domain_scores_codex":[0.9982423,0.001050203,0.0001824796,0.000240029,0.0001409878,0.0001440427],"domain_scores_gemma":[0.998505,0.0004566867,0.0004891414,0.0001022659,0.0001231604,0.0003237717],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9849538,0.002031845,0.0002865713,0.00193177,0.001705518,0.00003254649,0.0000205338,0.0001323898,0.0006390719,0.000143124,0.0005930554,0.007529934],"study_design_scores_gemma":[0.9900282,0.00839951,0.0003847441,0.00006612302,0.0004818668,0.00001366472,0.000006071687,0.0001113015,0.00005814515,0.00005935975,0.0003858038,0.000005220616],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8953974,0.05381393,0.002831227,0.003965749,0.004566167,0.02713867,0.004481106,0.0003787652,0.007426913],"genre_scores_gemma":[0.9332957,0.01834507,0.004837378,0.003873521,0.002336114,0.02964089,0.003112277,0.00004375136,0.004515425],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008377435,"threshold_uncertainty_score":0.02802533,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03101811218743415,"score_gpt":0.3744055311444537,"score_spread":0.3433874189570196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}